The Journal of Experimental Medicine
for flow cytometry > invitrogen
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article
Right arrow Full Text
Right arrow Full Text (PDF, 371K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rajotte, D.
Right arrow Articles by Hoang, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rajotte, D.
Right arrow Articles by Hoang, T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
© The Rockefeller University Press, 0022-1007/1997/6/1939/ $5.00
The Journal of Experimental Medicine, Volume 185, Number 11, June 2, 1997 1939-1950


Articles

Crucial Role of the Residue R280 at the F'–G' Loop of the Human Granulocyte/Macrophage Colony-stimulating Factor Receptor {alpha} Chain for Ligand Recognition

D. Rajotte*, C. Cadieux*, A. Haman*, B.C. Wilkes{ddagger},§, S.C. Clark**, T. Hercus{dagger}{dagger}, J.A. Woodcock{dagger}{dagger}, A. Lopez{dagger}{dagger}, and T. Hoang*,§,||

From the * Clinical Research Institute of Montréal, Laboratory of Hemopoiesis and Leukemia, and {ddagger} Laboratory of Biological Chemistry, Montréal, Quebec H2W 1R7, Canada; § Department of Pharmacology, || Department of Biochemistry, and Department of Molecular Biology, University of Montréal, Montréal, Quebec H3C 3J7, Canada; ** The Genetics Institute, Cambridge, Massachusetts 02140; and {dagger}{dagger} Hanson Cancer Center, Adelaide 5000, Australia

The receptor for granulocyte/macrophage colony-stimulating factor (GM-CSF) is composed of two chains, {alpha} and βc. Both chains belong to the superfamily of cytokine receptors characterized by a common structural feature, i.e., the presence of at least two fibronectin-like folds in the extracellular domain, which was first identified in the growth hormone receptor. The GM-CSF receptor (GMR)-{alpha} chain confers low affinity binding only (5–10 nM), whereas the other chain, βc, does not bind GM-CSF by itself but confers high affinity binding when associated with GMR-{alpha} (25–100 pM). The present study was designed to define the assembly of the GMR complex at the molecular level through site-directed mutagenesis guided by homology modeling with the growth hormone receptor complex. In our three-dimensional model, R280 of GMR-{alpha}, located in the F'–G' loop and close to the WSSWS motif, is in the vicinity of the ligand Asp112, suggesting the possibility of electrostatic interaction between these two residues. Through site directed mutagenesis, we provide several lines of evidence indicating the importance of electrostatic interaction in ligand–receptor recognition. First, mutagenesis of GMR-{alpha}R280 strikingly ablated ligand binding in the absence of β common (βc); ligand binding was restored in the presence of βc with, nonetheless, a significant shift from high (26 pM) toward low affinity (from 2 to 13 nM). The rank order of the dissociation constant for the different GMR-{alpha}R280 mutations where Lys > Gln > Met > Asp, suggesting the importance of the charge at this position. Second, a mutant GM-CSF with charge reversal mutation at position Asp112 exhibited a 1,000-fold decrease in affinity in receptor binding, whereas charge ablation or conservative mutations were the least affected (10–20-fold). Third, removal of the charge at position R280 of GMR-{alpha} introduced a 10-fold decrease in the association rate constant and only a 2-fold change in the dissociation rate constant, suggesting that R280 is implicated in ligand recognition, possibly through interaction with Asp112 of GM-CSF. For all R280 mutants, the half-efficient concentrations of GM-CSF required for membrane (receptor binding) to nuclear events (c-fos promoter activation) and cell proliferation (thymidine incorporation) were in the same range, indicating that the threshold for biologic activity is governed mainly by the affinity of ligand–receptor interaction. Furthermore, mutation of other residues in the immediate vicinity of R280 was less drastic. Sequence alignment and modeling of interleukin (IL)-3R and IL-5R identified an arginine residue at the tip of a β turn in a highly divergent context at the F'–G' loop, close to a conserved structural element, the WSXWS motif, suggesting the possibility of a ligand association mechanism similar to the one described herein for GMR.


Address correspondence to Dr. Trang Hoang, Clinical Research Institute of Montreal, 110 Pine Ave. West, Montréal, Québec H2W 1R7, Canada.

C. Cadieux and D. Rajotte contributed equally to this work.

1Abbreviations used in this paper: βc, β common; aa, amino acid; CHO, Chinese hamster ovary; CRM, cytokine receptor motif; GH, growth hormone; GMR, GM-CSF receptor; hGH, human growth hormone; NIH, National Institutes of Health.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS